Intrauterine growth restriction

International Journal of Gynecology and Obstetrics

Volumn 93, Issue 1, 2006, Pages 5-12

  Haram, K ^a   Softeland E ^a   Bukowski, R ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Diagnosis; Intrauterine growth restriction; Small for gestational age; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFECTIVE AGENT; BETAMETHASONE; CORTICOSTEROID; ENOXAPARIN; GLUCOCORTICOID; GLYCERYL TRINITRATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NITRIC OXIDE; PREDNISONE; STEROID; THEOPHYLLINE; VITAMIN K GROUP;

AGE DETERMINATION; AMNION FLUID; ANTIPHOSPHOLIPID SYNDROME; ASTHMA; BED REST; BRAIN DAMAGE; BRAIN HEMORRHAGE; CHEMOPROPHYLAXIS; CHILD DEATH; CLINICAL TRIAL; COMPARATIVE STUDY; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG INDICATION; FETAL HEMORRHAGE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GROWTH RETARDATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HERPES SIMPLEX; HIGH RISK POPULATION; HIGH RISK PREGNANCY; HORMONAL THERAPY; HUMAN; INFECTION PREVENTION; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; MALARIA; MATERNAL DISEASE; MEASUREMENT; META ANALYSIS; OXYGEN THERAPY; PERINATAL INFECTION; PERINATAL MORBIDITY; PERINATAL MORTALITY; PERIODONTAL DISEASE; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PRENATAL CARE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROPHYLAXIS; PROTOZOAL INFECTION; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR; RISK REDUCTION; RUBELLA; SECOND TRIMESTER PREGNANCY; SEPSIS; SUPPLEMENTATION; SURVIVAL RATE; SYPHILIS; SYSTEMATIC REVIEW; THREE DIMENSIONAL ECHOCARDIOGRAPHY; THROMBOPHILIA; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT INDICATION; TREATMENT OUTCOME; UMBILICAL ARTERY; UTERUS FUNDUS HEIGHT;

EID: 33645917672     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2005.11.011     Document Type: Review

References (71)

1. Harkness U.F., and Mari G. Diagnosis and management of intrauterine growth restriction. Clin Perinatol 31 (2004) 743-764 vi
2. Geirsson R.T. Ultrasound: the rational way to determine gestational age. Fetal Matern Med Rev 9 (1997) 133-146
3. Altman D.G., and Chitty L.S. New charts for ultrasound dating of pregnancy. Ultrasound Obstet Gynecol 10 (1997) 174-191
4. Hadlock F.P., Deter R.L., Harrist R.B., and Park S.K. Fetal head circumference: relation to menstrual age. AJR Am J Roentgenol 138 (1982) 649-653
5. Johnsen S.L., Rasmussen S., Sollien R., and Kiserud T. Fetal age assessment based on ultrasound head biometry and the effect of maternal and fetal factors. Acta Obstet Gynecol Scand 83 (2004) 716-723
6. Chervenak F.A., Skupski D.W., Romero R., Myers M.K., Smith-Levitin M., Rosenwaks Z., et al. How accurate is fetal biometry in the assessment of fetal age?. Am J Obstet Gynecol 178 (1998) 678-687
7. Baschat A.A. Pathophysiology of fetal growth restriction: implications for diagnosis and surveillance. Obstet Gynecol Surv 59 (2004) 617-627
8. American College of Obstetricians and Gynecologists. Intrauterine growth restriction. Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 72 (2001) 85-96
9. Loeffler F.E. Clinical foetal weight prediction. J Obstet Gynaecol Br Commonw 74 (1967) 675-677
10. Bais J.M., Eskes M., Pel M., Bonsel G.J., and Bleker O.P. Effectiveness of detection of intrauterine growth retardation by abdominal palpation as screening test in a low risk population: an observational study. Eur J Obstet Gynecol Reprod Biol 116 (2004) 164-169
11. Jacobsen G. Prediction of fetal growth deviations by use of symphysis-fundus height measurements. Int J Technol Assess Health Care 8 Suppl 1 (1992) 152-159
12. Lu M.C., Tache V., Alexander G.R., Kotelchuck M., and Halfon N. Preventing low birth weight: is prenatal care the answer?. J Matern Fetal Neonatal Med 13 (2003) 362-380
13. Neilson J.P. Symphysis-fundal height measurement in pregnancy (Cochrane review). The Cochrane Library (2004) 1-9
14. Mongelli M., and Gardosi J. Symphysis-fundus height and pregnancy characteristics in ultrasound-dated pregnancies. Obstet Gynecol 94 (1999) 591-594
15. Steingrimsdottir T., Cnattingius S., and Lindmark G. Symphysis-fundus height: construction of a new Swedish reference curve, based on ultrasonically dated pregnancies. Acta Obstet Gynecol Scand 74 (1995) 346-351
16. Gardosi J., and Francis A. Controlled trial of fundal height measurement plotted on customised antenatal growth charts. Br J Obstet Gynaecol 106 (1999) 309-317
17. Dudley N.J. A systematic review of the ultrasound estimation of fetal weight. Ultrasound Obstet Gynecol 25 (2005) 80-89
18. Warsof S.L., Cooper D.J., Little D., and Campbell S. Routine ultrasound screening for antenatal detection of intrauterine growth retardation. Obstet Gynecol 67 (1986) 33-39
19. Royston P., and Wright E.M. How to construct 'normal ranges' for fetal variables. Ultrasound Obstet Gynecol 11 (1998) 30-38
20. Lin C.C., Sheikh Z., and Lopata R. The association between oligohydramnios and intrauterine growth retardation. Obstet Gynecol 76 (1990) 1100-1104
21. Vandenbosche R.C., and Kirchner J.T. Intrauterine growth retardation. Am Fam Physician 58 (1998) 1384-1390
22. Chauhan S.P., Doherty D.D., Magann E.F., Cahanding F., Moreno F., and Klausen J.H. Amniotic fluid index vs. single deepest pocket technique during modified biophysical profile: a randomized clinical trial. Am J Obstet Gynecol 191 (2004) 661-667
23. Ott W.J. Reevaluation of the relationship between amniotic fluid volume and perinatal outcome. Am J Obstet Gynecol 192 (2005) 1803-1809
24. Banks E.H., and Miller D.A. Perinatal risks associated with borderline amniotic fluid index. Am J Obstet Gynecol 180 (1999) 1461-1463
25. Gardosi J. The application of individualised fetal growth curves. J Perinat Med 26 (1998) 333-338
26. Gardosi J. Customized fetal growth standards: rationale and clinical application. Semin Perinatol 28 (2004) 33-40
27. Mongelli M., and Gardosi J. Reduction of false-positive diagnosis of fetal growth restriction by application of customized fetal growth standards. Obstet Gynecol 88 (1996) 844-848
28. Gardosi J., Chang A., Kalyan B., Sahota D., and Symonds E.M. Customised antenatal growth charts. Lancet 339 (1992) 283-287
29. Alfirevic Z., and Neilson J.P. Doppler ultrasonography in high-risk pregnancies: systematic review with meta-analysis. Am J Obstet Gynecol 172 (1995) 1379-1387
30. Nienhuis S.J., Vles J.S., Gerver W.J., and Hoogland H.J. Doppler ultrasonography in suspected intrauterine growth retardation: a randomized clinical trial. Ultrasound Obstet Gynecol 9 (1997) 6-13
31. McCowan L.M., Harding J.E., Roberts A.B., Barker S.E., Ford C., and Stewart A.W. A pilot randomized controlled trial of two regimens of fetal surveillance for small-for-gestational-age fetuses with normal results of umbilical artery Doppler velocimetry. Am J Obstet Gynecol 182 (2000) 81-86
32. Dashe J.S., McIntire D.D., Lucas M.J., and Leveno K.J. Effects of symmetric and asymmetric fetal growth on pregnancy outcomes. Obstet Gynecol 96 (2000) 321-327
33. Pearce J.M., and Robinson G. Fetal growth and intrauterine growth retardation. In: Chamberlain G. (Ed). Turnbull's Obstetrics. second ed. (1995), Churchill Livingstone, Edinburgh 299-312
34. Snijders R.J., Sherrod C., Gosden C.M., and Nicolaides K.H. Fetal growth retardation: associated malformations and chromosomal abnormalities. Am J Obstet Gynecol 168 (1993) 547-555
35. Wladimiroff J.W., vd Wijngaard J.A., Degani S., Noordam M.J., van Eyck J., and Tonge H.M. Cerebral and umbilical arterial blood flow velocity waveforms in normal and growth-retarded pregnancies. Obstet Gynecol 69 (1987) 705-709
36. Khan N.A., and Kazzi S.N. Yield and costs of screening growth-retarded infants for torch infections. Am J Perinatol 17 (2000) 131-135
37. Offenbacher S., Lieff S., Boggess K.A., Murtha A.P., Madianos P.N., Champagne C.M., et al. Maternal periodontitis and prematurity. Part I. Obstetric outcome of prematurity and growth restriction. Ann Periodontol 6 (2001) 164-174
38. Eslick G.D., Yan P., Xia H.H., Murray H., Spurrett B., and Talley N.J. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther 16 (2002) 1677-1682
39. Gülmezoglu M., de O.M., and Villar J. Effectiveness of interventions to prevent or treat impaired fetal growth. Obstet Gynecol Surv 52 (1997) 139-149
40. Elimian A., Verma U., Canterino J., Shah J., Visintainer P., and Tejani N. Effectiveness of antenatal steroids in obstetric subgroups. Obstet Gynecol 93 (1999) 174-179
41. Bernstein I.M., Horbar J.D., Badger G.J., Ohlsson A., Golan A., and The Vermont Oxford Network. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. Am J Obstet Gynecol 182 (2000) 198-206
42. Schaap A.H., Wolf H., Bruinse H.W., Smolders-De Haas H., Van E.I., and Treffers P.E. Effects of antenatal corticosteroid administration on mortality and long-term morbidity in early preterm, growth-restricted infants. Obstet Gynecol 97 (2001) 954-960
43. Crowley P.A. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 173 (1995) 322-335
44. Vermillion S.T., Soper D.E., and Newman R.B. Neonatal sepsis and death after multiple courses of antenatal betamethasone therapy. Am J Obstet Gynecol 183 (2000) 810-814
45. Chammas M.F., Nguyen T.M., Li M.A., Nuwayhid B.S., and Castro L.C. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?. Am J Obstet Gynecol 183 (2000) 853-858
46. Senat M.V. Corticosteroid for fetal lung maturation: indication and treatment protocols. J Gynecol Obstet Biol Reprod (Paris) 31 (2002) 5S105-5S113
47. Autret-Leca E., and Jonville-Bera A.P. Vitamin K in neonates: how to administer, when and to whom. Paediatr Drugs 3 (2001) 1-8
48. Suzuki S., Iwata G., and Sutor A.H. Vitamin K deficiency during the perinatal and infantile period. Semin Thromb Hemost 27 (2001) 93-98
49. Crowther C.A., and Henderson-Smart D.J. Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage. Cochrane Database Syst Rev (2001) CD000229
50. Walker M.C., Ferguson S.E., and Allen V.M. Heparin for pregnant women with acquired or inherited thrombophilias. Cochrane Database Syst Rev (2003) CD003580
51. Brenner B., and Kupferminc M.J. Inherited thrombophilia and poor pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 17 (2003) 427-439
52. Leitich H., Egarter C., Husslein P., Kaider A., and Schemper M. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 104 (1997) 450-459
53. Coomarasamy A., Honest H., Papaioannou S., Gee H., and Khan K.S. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 101 (2003) 1319-1332
54. Vainio M., Kujansuu E., Iso-Mustajarvi M., and Maenpaa J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 109 (2002) 161-167
55. Vainio M., Kujansuu E., Iso-Mustajarvi M., and Maenpaa J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. Br J Obstet Gynaecol 109 (2002) 161-167
56. Ural S., and Nagey D.A. Preventing intrauterine growth retardation with aspirin: does it work?. Birth 25 (1998) 54-55
57. Uzan S., Beaufils M., Dumont A., Merviel P., Challier J.C., and Breart G. Does aspirin still have a role during pregnancy?. Fetal Diagn Ther 13 (1998) 131-132
58. Uzan S. Aspirin and prevention of vascular complications: there are still indications. Ultrasound Obstet Gynecol 15 (2000) 4-6
59. Kupferminc M.J., Fait G., Many A., Lessing J.B., Yair D., Bar-Am A., et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 20 (2001) 35-44
60. Allahbadia G.N., and Allahbadia S.G. Low molecular weight heparin in immunological recurrent abortion-the incredible cure. J Assist Reprod Genet 20 (2003) 82-90
61. Franklin R.D., and Kutteh W.H. Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro. Obstet Gynecol 101 (2003) 455-462
62. Franklin R.D., and Kutteh W.H. Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro. Obstet Gynecol 101 (2003) 455-462
63. Laskin C.A., Bombardier C., Hannah M.E., Mandel F.P., Ritchie J.W., Farewell V., et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 337 (1997) 148-153
64. Rai R., Cohen H., Dave M., and Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314 (1997) 253-257
65. Say L., Gulmezoglu A.M., and Hofmeyr G.J. Hormones for suspected impaired fetal growth 8. Cochrane Database Syst Rev (2003) CD000109
66. Greenberger P.A., and Patterson R. The outcome of pregnancy complicated by severe asthma. Allergy Proc 9 (1988) 539-543
67. Bracken M.B., Triche E.W., Belanger K., Saftlas A., Beckett W.S., and Leaderer B.P. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol 102 (2003) 739-752
68. Schatz M., Zeiger R.S., Hoffman C.P., Harden K., Forsythe A., Chilingar L., et al. Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis. Am J Respir Crit Care Med 151 (1995) 1170-1174
69. Say L., Gulmezoglu A.M., and Hofmeyr G.J. Maternal oxygen administration for suspected impaired fetal growth 7. Cochrane Database Syst Rev (2003) CD000137
70. Lees C., Valensise H., Black R., Harrington K., Byiers S., Romanini C., et al. The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of pre-eclampsia and its complications: a randomized double-blind placebo-controlled trial. Ultrasound Obstet Gynecol 12 (1998) 334-338
71. Gülmezoglu A.M., and Hofmeyr G.J. Bed rest in hospital for suspected impaired fetal growth. Cochrane Database Syst Rev (2000) CD000034